1. Adjuvant capecitabine resulted in fewer instances of disease recurrence and death compared to standard therapy.
2. Overall and failure-free survival at 3 years was significantly greater in the capecitabine group.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Nasopharyngeal carcinoma is a form of invasive head and neck cancer with a favorable...
1. Intensity-modulated proton therapy was associated with fewer adverse events than intensity-modulated radiation therapy in the treatment of patients with nonmetastatic nasopharyngeal carcinoma.
2. Both therapies achieved equivalently good oncologic outcomes over a two year follow-up period.
Evidence Rating Level: 2 (Good)
Study Rundown: Nasopharyngeal carcinoma (NPC) is routinely treated with radiation...